Cargando…
VCAM-1 targeted alpha-particle therapy for early brain metastases
BACKGROUND: Brain metastases (BM) develop frequently in patients with breast cancer. Despite the use of external beam radiotherapy (EBRT), the average overall survival is short (6 months from diagnosis). The therapeutic challenge is to deliver molecularly targeted therapy at an early stage when rela...
Autores principales: | Corroyer-Dulmont, Aurélien, Valable, Samuel, Falzone, Nadia, Frelin-Labalme, Anne-Marie, Tietz, Ole, Toutain, Jérôme, Soto, Manuel Sarmiento, Divoux, Didier, Chazalviel, Laurent, Pérès, Elodie A, Sibson, Nicola R, Vallis, Katherine A, Bernaudin, Myriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162423/ https://www.ncbi.nlm.nih.gov/pubmed/31538194 http://dx.doi.org/10.1093/neuonc/noz169 |
Ejemplares similares
-
Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases
por: Falzone, Nadia, et al.
Publicado: (2018) -
Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2021) -
Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [(64)Cu][Cu(ATSM)] PET and proteomic studies
por: Fantin, Jade, et al.
Publicado: (2023) -
Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2021) -
Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma models
por: Leblond, Marine M, et al.
Publicado: (2015)